Development of Radiation/Nuclear Medical Countermeasures (MCMs) or Biodosimetry Devices

Award Notice Posted

Solicitation number
BAA-75N93022R00021
Agency
Awarded
to Duke University
Set-aside
No set-aside

Opportunity facts

Contract number
75N93024C00005 Federal contract award
Place of performance
Durham, North Carolina 27705, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute of Allergy and Infectious Diseases awarded Duke University a non-severable cost reimbursement completion type contract with non-severable options under the Broad Agency Announcement for the "Development of Radiation/Nuclear Medical Countermeasures (MCMs) and Bio-dosimetry Devices". The contract value is $601,208.60 to develop radiation/nuclear medical countermeasures and biodosimetry devices to help the agency address public health emergencies involving radiation and nuclear exposure over the contract period.

Notice text

The National Insitute of Allergy and Infectious Diseases has awarded a non-severable cost reimbursement completion type contract with non-severable Options under the Broad Agency Announcement, titled "Development of Radiation/Nuclear Medical Countermeasures (MCMs) and Bio-dosimetry Devices". 

Awarded contract 75N93024C00005 to DUKE UNIVERSITY for 6012086.00 on 2024-02-29.

Notice history

Notice Type Posted
Development of Radiation/Nuclear Medical Countermeasures (MCMs) or Biodosimetry Devices Latest Award Notice
This notice Award Notice
Development of Radiation/Nuclear Medical Countermeasures (MCMs) or Biodosimetry Devices Latest solicitation Solicitation
Development of Radiation/Nuclear Medical Countermeasures (MCMs) or Biodosimetry Devices Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors